Despite advances in care for patients with head and neck cancer, the advanced form of the disease is difficult to treat and ...

The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

The Trump administration's decision to cut $500 million for new vaccine development raises concerns among health care administrators at UC Davis about potential risks during future outbreaks.

A long list of medical experts are saying Robert F. Kennedy Jr.'s decision to cut mRNA research will set back the country’s ...

Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

Stocks in the health-care industry rose as markets grew more confident that U.S. borrowing costs will fall, while companies in the sector pleased investors in their quarterly reports. Gilead Sciences ...

Texas Gov. Greg Abbott vowed Thursday in an interview with NBC News to call “special session after special session after special session” until state Republicans can pass new maps to pad the party’s ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

HHS Secretary Kennedy’s decision is based on a fundamental misunderstanding of vaccinology that could cost lives in future pandemics.

GSK said it will receive $370 million as part of the U.S. patent settlement involving CureVac and BioNTech over mRNA-based COVID-19 vaccines, The Wall Street Journal reported Aug. 8. Under the deal, ...